DIGITAL EDITIONS

Day: June 1, 2019

June 2019 Digital Edition

June 1, 2019

Click the cover below to access the June 2019 digital edition of JCAD!

VOL. 12, NO. 6 • JUNE 2019 Dear Colleagues: Welcome to the June 2019 issue of The Journal of Clinical and Aesthetic Dermatology (JCAD). In this issue, we are pleased to present the article “Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS),” by Del Rosso, Tanghetti, Webster, Stein Gold,

Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update

June 1, 2019

Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has been approved by the United States Food and Drug Administration for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. An increasing number of studies have demonstrated the efficacy of tofacitinib in treatment of alopecia areata (AA).1–6 Treatment duration in these studies

Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS)

June 1, 2019

J Clin Aesthet Dermatol. 2019;12(6):17–24 by James Q. Del Rosso, DO, FAOCD, FAAD; Emil Tanghetti, MD, FAAD; Guy Webster, MD, PhD, FAAD; Linda Stein Gold, MD, FAAD; Diane Thiboutot, MD, FAAD; and Richard L. Gallo, MD, PhD, FAAD Dr. Del Rosso is Adjunct Clinical Professor of Dermatology at Touro University, Nevada in Henderson, Nevada; and

Coprescription of Isotretinoin and Systemic Corticosteroids for Acne: An Analysis of the National Ambulatory Medical Care Survey

June 1, 2019

J Clin Aesthet Dermatol. 2019;12(6):27–28 by Brooke Vasicek, MD; William Adams, PhD; Laryn Steadman, BFA; Jeave Reserva, MD; and James Swan, MD Drs. Vasicek, Reserva, and Swan are with the Division of Dermatology at the Loyola University Medical Center in Hines, Illinois. Dr. Adams is with the Biostatistics Core, Health Sciences Division at the Loyola University